Is There a Correlation Between the Pulmonary Artery Pressure and the Acceleration of the Flow in the Pulmonary Artery Evaluated by Transesophageal Echocardiography (TOE) ?
NCT01947257 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50
Last updated 2014-09-01
Summary
The measure of the pulmonary artery pressure (PAP) is a very useful index in intensive care to estimate right ventricular after load. The reference technique for this measure is the right catheterism which is an invasive technique. It is possible to estimate the pulmonary artery pressure by using transthoracic echocardiography (TTE) which allows, using the continuous Doppler, the measure of maximum speed of tricuspid regurgitation (TRvmax). The measure of the TRvmax can however be difficult for intensive care patients with little echogenicity or impossible for those having no tricuspid leak. The evaluation of the tricuspid regurgitation is also particularly difficult using TOE. To avoid these drawbacks, one can use the analysis of the pulmonary ejection in the pulmonary artery (PAAT) with TOE. However, the data of the literature are controversial on this method and it was not validated in mechanically ventilated intensive care patients.
The aim of this work is to compare three methods of measure of the PAP: the measure TRVMAX (by means of the tricuspid leak) by transthoracic echocardiography, the measure of the TAAP by transesophageal ultrasound and the direct measure of the pulmonary pressures by right catheterization, in ventilated patients already monitored with a catheter in the right cavities for usual indications in intensive care (ARDS, shock). We shall analyze then the correlation between the TRVmax, the TAAP and the pressures measured by the right catheterism which serves as reference technique.
Conditions
- Ventilated Patients
Interventions
- OTHER
-
the measure TRVMAX
by transthoracic echocardiography
- OTHER
-
the measure of the pulmonary artery
by transesophageal ultrasound
- OTHER
-
the direct measure of the pulmonary pressures
by right catheterization
Sponsors & Collaborators
-
Assistance Publique Hopitaux De Marseille
lead OTHER
Principal Investigators
-
LOIC MONDOLONI · Assistance Publique Hopitaux De Marseille
Study Design
- Allocation
- NA
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2013-09-30
- Primary Completion
- 2014-07-31
- Completion
- 2015-01-31
Countries
- France
Study Locations
More Related Trials
-
PV Loop and Pulmonary Hypertension
NCT05484596 ·Status: UNKNOWN
-
CTEPH Predictors Following Acute Pulmonary Embolism
NCT05784896 ·Status: UNKNOWN
-
Prevalence and Risk Factors of Pulmonary Hypertension in Patients with Myeloproliferative Neoplasms in Assiut University Hospital.
NCT06647706 ·Status: NOT_YET_RECRUITING
-
Thrombo Embolic Events in Critical Care Patients With Covid-19 Serious Acute Pneumopathy
NCT04366752 ·Status: COMPLETED
-
Symptom-driven Referral for Evaluation of Chronic Thromboembolic Disease or Pulmonary Hypertension in Patients With Previous Acute Pulmonary Embolism
NCT03729492 ·Status: UNKNOWN ·Phase: NA
-
OCT Evaluates the Effects of CTEPH Treated by Scoring Balloon
NCT05480137 ·Status: UNKNOWN ·Phase: NA
-
Clinical, Radiological, Tissue and Biological Phenotyping for the Analysis of the Transition From Physiology to Pathology in Pulmonary Diseases With Pulmonary Hypertension
NCT07184671 ·Status: NOT_YET_RECRUITING
-
3D Imaging: Prognostic Role in Pulmonary Arterial Hypertension
NCT02799979 ·Status: UNKNOWN
-
Prognostic Value of Plasma Lactate Levels Among Patients With Acute Pulmonary Embolism
NCT01908231 ·Status: COMPLETED
-
Assessment of the Risk of Pulmonary Embolism and Coagulation Profile in Patients With COVID-19 Lung Disease
NCT04479540 ·Status: COMPLETED ·Phase: NA
-
Non-Invasive Measurement of Cardiac Output and Stroke Volume in PAH/CTEPH
NCT05618093 ·Status: WITHDRAWN ·Phase: NA
-
Perioperative Portal Vein Pulsatility as a Postoperative Prognostic Indicator in Pulmonary Endarterectomy
NCT03197792 ·Status: UNKNOWN ·Phase: NA
-
Prognostic Value of Estimated Plasma Volume in Pulmonary Hypertension
NCT05861479 ·Status: COMPLETED
-
Evaluating the Use of Thromboelastography (TEG) in Patient's Requiring Extracorporeal Membrane Oxygenation (ECMO)
NCT02887820 ·Status: TERMINATED ·Phase: NA
-
COVID-19, bLOod Coagulation and Thrombosis
NCT04388657 ·Status: UNKNOWN
-
Evaluation of the Prevalence of Pulmonary Hypertension in Adult Patients With Sickle Cell Disease
NCT00434902 ·Status: UNKNOWN
-
PIMR and Pulmonary Vascular Disease
NCT05843461 ·Status: COMPLETED
-
Evolution of Pulmonary Capillary Blood Volume
NCT00941187 ·Status: COMPLETED
-
Assessment of Blood Coagulation Disorders in Patients With Pulmonary Hypertension
NCT03195543 ·Status: UNKNOWN
-
CTEPH Identification an Standard Computerised Tomography Pulmonary Angiography in Pulmonary Embolism Patients
NCT03083093 ·Status: COMPLETED
-
Evaluation of Latent Pulmonary Arterial Hypertension in Congenital Shunt Lesions
NCT02552485 ·Status: COMPLETED
-
Changes of Cardiopulmonary Function After Thrombolysis in Patients With Pulmonary Embolism
NCT04757129 ·Status: RECRUITING
-
Screening for Individual Susceptibility Factors to Immersion Pulmonary Edema
NCT05049889 ·Status: RECRUITING ·Phase: NA
-
Pulmonary Perfusion by Iodine Subtraction Mapping CT Angiography in Acute Pulmonary Embolism
NCT03579849 ·Status: COMPLETED ·Phase: NA
-
Standard vs. Ultrasound-assisted Catheter Thrombolysis for Submassive Pulmonary Embolism
NCT02758574 ·Status: COMPLETED ·Phase: NA